Research from Water Tower Research, Water Tower Research

Water Tower Research

Water Tower Research is a leading equity research firm that provides research on micro, small and mid cap companies.

Water Tower Research was founded by Wall Street veterans after witnessing a fundamental shift in the investment research industry with the result being a declining knowledge base among investors, a lack of awareness and a shrinking pool of fundamental research being conducted on companies across the small-cap and micro-cap spectrum. The same issues are now increasingly occurring in the mid-cap space. This sea change within the investment community is impacting not only the companies themselves but also current shareholders and potential investors. With significantly less active sell-side sponsorship by Wall Street, a substantial information gap has developed between companies and various constituents in the financial community. The net result is fewer channels for insight and information to flow between companies and investors.

Research from Water Tower Research

Equity Research Firm

Equity Bottom-Up

<ul><li>SCN revenue-powered 3Q25. Vivos Therapeutics (NASDAQ: VVOS) delivered a strong quarter, reporting a 76% Y/Y revenue surge from $3.9 million to $6.8 million, fueled by the first full-quarter contribution from Sleep Center of Nevada (SCN), which Vivos acquired on June 10, 2025. </li><li>The $2.9-million revenue accretion consisted of a $2.2-million increase in OSA sleep testing services, primarily generated by SCN, and $1.3 million generated from treatment centers known as Sleep and Airway Medicine Centers (SAMCs) launched at two SCN locations in Las Vegas. </li><li>This was partially offset by a $0.8-million drop in VIP revenue, a deliberate diminution from this source, reflecting management’s strategic decision to pivot away from the legacy channel.</li></ul>

SCN revenue-powered 3Q25. Vivos Therapeutics (NASDAQ: VVOS) delivered a strong quarter, reporting a 76% Y/Y revenue surge from $3.9 million to $6.8 million, fueled by the first full-quarter contribution from Sleep Center of Nevada (SCN), which Vivos acquired on June 10, 2025. The $2.9-million revenue accretion consisted of a $2.2-million increase in OSA sleep testing services, primarily generated by SCN, and $1.3 million generated from treatment centers known as Sleep and Airway Medicine Centers (SAMCs) launched at two SCN locations in Las Vegas. This was partially offset by a $0.8-million drop in VIP revenue, a deliberate diminution from this source, reflecting management’s strategic decision to pivot away from the legacy channel.

VVOS: Strong Quarter Builds Platform for Continuing Growth Momentum